Your search for major depressive disorder returned 96 results

A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often misdiagnosed. We spoke with Richard Bogan, MD, FCCP, FAASM, associate clinical professor at the University of the South Carolina School of Medicine about IH and criteria for diagnosing this sleep disorder.

Over 60% of people with Parkinson’s disease will have REM sleep behavior disorder, endangering them and their partners during the night.

In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.

Two experts speak about how apps address different needs and use different technologies, but taken together, they shed light on the manifold ways that apps can be used for depression management in clinical practice.

Research study results showed that treatments for multiple sclerosis precipitated headaches and migraines.

In an interview, sleep medicine experts Milena K Pavlova, MD, and Rachel Ziegler, MD, discuss the latest developments in sleep disorder therapies and the existing gaps in sleep medicine.

A multi-faceted approach is best when treating pediatric headache.

David Howell, PhD; and Heather Sesma, PhD; provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.

Danny Eckert, PhD, a researcher on human sleep and respiratory physiology, explains the potential bidirectional relationship and the clinical complications of COMISA, comorbid insomnia and sleep apnea.

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.

The widespread use of cannabis and the public perception that it is harmless make screening and patient counseling a priority.

Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.

Perhaps it is that tension between undeniable differences and inevitable merging that has led to more recent calls for cross-disciplinary cooperation.

Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.

Debate continues as to whether ocular tremor represents a clinical marker of Parkinson’s disease or a compensatory movement related to other bodily tremors.

The authors highlight what is known about the development of new daily persistent headache (NDPH), explain how to diagnose and manage patients with NDPH, and discuss possible future therapies.

DBS has been known to generate other movement-related disorders such as dyskinesias, blepharospasm, and hypokinesia.

As the most effective treatment for a patient with multiple sclerosis is one that is specifically tailored to the patient’s individual needs and preferences, recognition of the unique characteristics, preferences, and trends shared by the millennial generation should drive innovative solutions.

Catastrophizing makes pain more painful, makes it last longer, and makes pain much harder to treat.

NP expert discusses screening and treatments for anxiety in children and adolescents in the primary care setting.

Research highlights the need for healthcare professionals to proactively and directly address the issues and risks of DMTs in terms of MS patients’ family planning activities.

Neurology advisor spoke with Charuta Joshi, MBBS regarding the use of the cannabis-based Epidiolex in the treatment of pediatric seizures.

Thomas Gillingwater, PhD, discusses how critical it is to start SMA treatment early in infants before the onset of symptoms.

Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.

Neurology Advisor spoke with Dr Peter McAllister about how to best discern migraine with aura from stroke.

Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.

Closed-loop neurostimulation technology is being investigated for movement disorders, headache, and even some neuropsychiatric disorders.

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.

Multiple system atrophy is a rare, progressive neurodegenerative condition for which there is currently no cure.

While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.